EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED

Guanhong Bu iD, Emma Danelius, Lianne H E Wieske iD, Tamir Gonen iD

Advanced Biology · 2024-05 · 8 (5)

DOI: 10.1002/adbi.202300570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 21.02.2024. Verfasst von Guanhong Bu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, University of California Los Angeles, 615 Charles E. Young Drive South, Los Angeles, CA, 90095, USA. Hauptthemen laut MEDLINE: Sulfonamides, Cyclopropanes, Lactams, Macrocyclic, Proline. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paritaprevir is an orally bioavailable, macrocyclic drug used for treating chronic Hepatitis C virus (HCV) infection. Its structures have been elusive to the public until recently when one of the crystal forms is solved by microcrystal electron diffraction (MicroED). In this work, the MicroED structures of two distinct polymorphic crystal forms of paritaprevir are reported from the same experiment. The different polymorphs show conformational changes in the macrocyclic core, as well as the cyclopropyl sulfonamide and methyl pyrazinamide substituents. Molecular docking shows that one of the conformations fits well into the active site pocket of the HCV non‐structural 3/4A (NS3/4A) serine protease target, and can interact with the pocket and catalytic triad via hydrophobic interactions and hydrogen bonds. These results can provide further insight for optimization of the binding of acyl sulfonamide inhibitors to the HCV NS3/4A serine protease. In addition, this also demonstrates the opportunity to derive different polymorphs and distinct macrocycle conformations from the same experiments using MicroED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesCyclopropanesLactams, MacrocyclicProlineMolecular Docking SimulationMacrocyclic CompoundsAntiviral AgentsHepacivirusViral Nonstructural Proteins

Stichwörter der Autor:innen

HCV proteaseMicroEDmacrocyclesmolecular chameleonspolymorphism

Substanzen

SulfonamidesCyclopropanesLactams, MacrocyclicProlineparitaprevirMacrocyclic CompoundsAntiviral AgentsViral Nonstructural Proteins

Autor:innen und Institutionen

  • Department of Biological Chemistry, University of California Los Angeles, 615 Charles E. Young Drive South, Los Angeles, CA, 90095, USA.
  • Howard Hughes Medical Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA.
  • Department of Chemistry-BMC, Uppsala University, Husargatan 3, Uppsala, 75237, Sweden.
  • Department of Physiology, University of California Los Angeles, 615 Charles E. Young Drive South, Los Angeles, CA, 90095, USA.

ORCID-Profile: Guanhong Bu, Lianne H E Wieske, Tamir Gonen

Förderung

  • Howard Hughes Medical Institute
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense

Zitieren

APA

Bu, G., Danelius, E., Wieske, L. H. E., & Gonen, T. (2024). Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED. Advanced Biology, 8(5). https://doi.org/10.1002/adbi.202300570

Vancouver

Bu G, Danelius E, Wieske LHE, Gonen T. Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED. Advanced Biology. 2024;8(5). doi:10.1002/adbi.202300570

BibTeX
@article{Bu2024,
  author = {Bu, Guanhong and Danelius, Emma and Wieske, Lianne H E and Gonen, Tamir},
  title = {Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED},
  journal = {Advanced Biology},
  year = {2024},
  volume = {8},
  number = {5},
  doi = {10.1002/adbi.202300570}
}
Kostenlos starten →